Wall Street faced renewed selling pressure on Wednesday as a confluence of energy market shocks and corporate strategy shifts weighed on investor sentiment.
The Nasdaq Composite fell sharply, dropping 2.7% by midday, reflecting broad-based risk aversion triggered by geopolitical escalation in the Middle East and sector-specific headwinds in healthcare.
Oil prices surged in early trading following reports of renewed attacks in the region, raising immediate concerns over potential disruptions to critical energy infrastructure.
The spike in crude costs acted as a drag on equity valuations, particularly for sectors sensitive to input costs and consumer spending power.
Brent crude climbed significantly as traders repriced the probability of supply constraints, with the move underscoring the persistent vulnerability of global energy flows to geopolitical instability.
Compounding the market downturn was news from Eli Lilly, which announced a strategic pivot regarding its next-generation obesity drug.